Frequently Asked Questions
The South East Asia Molecular Point of Care Testing (using NAAT) Market will grow at a CAGR of 8.9% by forecast.
The major players operating in the South East Asia Molecular Point of Care Testing (using NAAT) Market are Abbott, F.Hoffmann-La Roche Ltd., Danaher, Thermo Fisher Scientific Inc., BD, Biomérieux Sa, Qiagen, Quidel Corporation, Bio-Rad Laboratories, Inc., Randox Laboratories Ltd., Sysmex Corporation, Meridian Biosciences, Hologic Inc., Wondfo, and PerkinElmer Inc.
The significant factors flourishing the growth of the South East Asia Molecular Point of Care Testing (using NAAT) Market are INCREASE PREVALENCE OF CHRONIC DISEASES, and IMPROVEMENT IN DIAGNOSIS-SEEKING RATE.
The major countries covered in the South East Asia Molecular Point of Care Testing (using NAAT) Market are Singapore, Vietnam, Thailand, Malaysia, Indonesia, Philippines and the Rest of South East Asia.
